FFCP PHASE1:Mm9::chr5:89457122..89457129,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=54403|HGNC=|MCL_coexpression_id=11|UniProt=D3Z7G8|association_with_transcript=5bp_to_ENSMUST00000134303_5end|description=CAGE_peak_13_at_Slc4a4_5end|id=chr5:89457122..89457129,+|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002113!9.03e-26!14;UBERON:0003918!9.03e-26!14;UBERON:0005095!9.03e-26!14;UBERON:0007687!9.03e-26!14;UBERON:0006554!1.64e-22!16;UBERON:0001008!3.60e-21!17;UBERON:0000489!4.51e-17!21;UBERON:0003103!4.15e-08!43;UBERON:0005172!4.74e-07!49;UBERON:0005173!4.74e-07!49;UBERON:0002417!4.74e-07!49;UBERON:0000916!4.74e-07!49|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.92e-26,14;UBERON:0003918,1.92e-26,14;UBERON:0011143,1.92e-26,14;UBERON:0005095,1.92e-26,14;UBERON:0007687,1.92e-26,14;UBERON:0006554,1.05e-20,18;UBERON:0001008,1.21e-19,19;UBERON:0000489,7.93e-18,21;UBERON:0003103,6.12e-09,43;UBERON:0005172,6.88e-08,49;UBERON:0005173,6.88e-08,49;UBERON:0002417,6.88e-08,49;UBERON:0000916,6.88e-08,49|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.19060606211498,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.280888840263504,0,0,0,0,0,0,0,0,0,0,0.5709193985953,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.610953983535943,0.193952487167626,2.10407459670956,3.79419222745544,8.11855813887812,8.47793130343424,10.2419646055094,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.177475806159338,0,0,0,0.0846146078916765,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p13@Slc4a4}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:54403 | |||
|HGNC= | |||
|MCL_coexpression_id=11 | |||
|TSSclassifier=NA | |||
|UniProt=uniprot:D3Z7G8 | |||
|association_with_transcript=5bp_to_ENSMUST00000134303_5end | |||
|cluster_id=chr5:89457122..89457129,+ | |||
|description=CAGE_peak_13_at_Slc4a4_5end | |||
|id=chr5:89457122..89457129,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002113!9.03e-26!14;UBERON:0003918!9.03e-26!14;UBERON:0005095!9.03e-26!14;UBERON:0007687!9.03e-26!14;UBERON:0006554!1.64e-22!16;UBERON:0001008!3.60e-21!17;UBERON:0000489!4.51e-17!21;UBERON:0003103!4.15e-08!43;UBERON:0005172!4.74e-07!49;UBERON:0005173!4.74e-07!49;UBERON:0002417!4.74e-07!49;UBERON:0000916!4.74e-07!49 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.92e-26,14;UBERON:0003918,1.92e-26,14;UBERON:0011143,1.92e-26,14;UBERON:0005095,1.92e-26,14;UBERON:0007687,1.92e-26,14;UBERON:0006554,1.05e-20,18;UBERON:0001008,1.21e-19,19;UBERON:0000489,7.93e-18,21;UBERON:0003103,6.12e-09,43;UBERON:0005172,6.88e-08,49;UBERON:0005173,6.88e-08,49;UBERON:0002417,6.88e-08,49;UBERON:0000916,6.88e-08,49 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.19060606211498,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.280888840263504,0,0,0,0,0,0,0,0,0,0,0.5709193985953,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.610953983535943,0.193952487167626,2.10407459670956,3.79419222745544,8.11855813887812,8.47793130343424,10.2419646055094,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.177475806159338,0,0,0,0.0846146078916765,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p13@Slc4a4 | |||
}} |
Revision as of 17:33, 4 August 2015
Short description: | p13@Slc4a4 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_13_at_Slc4a4_5end |
Coexpression cluster: | MCL_coexpression_mm9:11 |
Association with transcript: | 5bp_to_ENSMUST00000134303_5end |
EntrezGene: | 54403 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
kidney | 1.92e-26 | 14 |
kidney mesenchyme | 1.92e-26 | 14 |
upper urinary tract | 1.92e-26 | 14 |
kidney rudiment | 1.92e-26 | 14 |
kidney field | 1.92e-26 | 14 |
urinary system structure | 1.05e-20 | 18 |
renal system | 1.21e-19 | 19 |
cavitated compound organ | 7.93e-18 | 21 |
compound organ | 6.12e-09 | 43 |
abdomen element | 6.88e-08 | 49 |
abdominal segment element | 6.88e-08 | 49 |
abdominal segment of trunk | 6.88e-08 | 49 |
abdomen | 6.88e-08 | 49 |